Tang JW, Lam TT, Zaraket H, et al. Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance. Lancet Infect Dis 2017; DOI:10.1016/S1473-3099(17)30238-4 —In the affiliations of this Personal View, the affiliation for J W Tang should read “Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, UK”, the affiliation for T T Lam should read “School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China”, the affiliation for H Zaraket should read “Department of Experimental Pathology, Immunology, and Microbiology, American University of Beirut, Beirut, Lebanon”, the affiliation for Prof W I Lipkin should read “Mailman School of Public Health, Columbia University , New York, NY, USA”, the affiliation for J-M Heraud should read “Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar”, and the affiliation for Prof M P Koopmans should read “Department of Viroscience, Erasmus Medical Centre, Rotterdam, Netherlands”.
A new influenza vaccine that is particularly effective at protecting people over the age of 65 has been approved for use by the UK ’s drug regulatory body and is expected to be available to GP practices from next year.
Equine influenza is a major health problem of equines worldwide. The polymerase genes of influenza virus have key roles in virus replication, transcription, transmission between hosts and pathogenesis. Hence, ...
CONCLUSIONS: The experimental vaccine three-antibody protection rate was non-inferior to the control vaccine. Our results demonstrated that the experimental vaccine achieved the primary immunogenic end point of the intended clinical protocol, as well as a secondary immunogenic end-point, with an acceptable level of safety. IRB approval for this study was issued under #2012Y0005 and registered as Clinical Trial No. NCT01551810. PMID: 28825515 [PubMed - as supplied by publisher]
Which patients should receive antiviral therapy for influenza, and what are the currently available options?U.S. Pharmacist
Influenza A virus (IAV) PB1-F2 protein has been linked to viral virulence. Strains of the H3N2 subtype historically express full-length PB1-F2 proteins but during the 2010 –2011 influenza seasons, nearly half o...
ConclusionFor both RA and non‐RA patients, compliance with Canadian recommendations for preventive medical services and screening for comorbid conditions in primary care was less than optimal. This indicates key targets for improvement.
In a head-to-head comparison, a quadrivalent recombinant influenza vaccine (RIV4) provided more protection in adults aged 50 years or older than a standard-dose, egg-grown, quadrivalent, inactivated influenza vaccine (IIV4). The vaccines were evaluated during the 2014-2015 influenza season, when an antigenic mismatch between circulating and vaccine influenza strains resulted in low vaccine efficacy, according to aNew England Journal of Medicinestudy.
You get one ailment, and it always seems to bring along its'friends'. A few examples are cancer with chemotherapy causes digestive issuesand temporary baldness. It can sometimes also cause long term cardiac issues - which can eventually kill you. With rheumatoid arthritis you can get things like Sjogren's Syndrome which causes dry eyes and other fun things. Afew examples are:" ... [RA]inflammation can result in conditions affecting skin, heart, lung, eyes, mental health, etc. Conditions likeosteoporosis, cataracts,depression, cancers, etc. are more common. And add to that infection based conditions like influenza, pne...
Analytical ChemistryDOI: 10.1021/acs.analchem.7b02514